From protocol to product: ventral midbrain dopaminergic neuron differentiation for the treatment of Parkinson's disease.
This report summaries key milestones in specifically for ventral midbrain dopaminergic neuroprogenitor differentiation and key translational considerations and recommendations to enable successful, robust and reproducible current cell therapy product-manufacturing.
PMID: 31718456 [PubMed - as supplied by publisher]
Source: Regenerative Medicine - Category: Genetics & Stem Cells Authors: Kusena JW, Thomas RJ, McCall MJ, Wilson SL Tags: Regen Med Source Type: research